# Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

> **NCT00501111** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 659 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** AZD3480
- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00501111
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2014-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501111, "Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00501111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*